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ess: djc_69_98@yahoo.Summary It has been stated that malignancy is the most common aetiology of
massive pleural effusions. To determine the most frequent causes of massive pleural
effusions and to assess the diagnostic yield of different diagnostic procedures and
survival, we prospectively studied 1084 patients with pleural effusion. Massive
pleural effusions were identified in 121 of 1084 patients (11.2%). Compared with
non-massive pleural effusions, massive pleural effusions were significantly more
likely to be malignant (53.7% vs. 38.3%, P ¼ 0:03) or secondary to cirrhosis (9.9% vs.
2.6%, P ¼ 0:0000). On the other hand, massive pleural effusions were significantly
less likely to be secondary to infection (10.7% vs. 19.2%, P ¼ 0:003) or congestive
heart failure (0.8% vs. 6.7%, P ¼ 0:03). There was a significant increase in the yield
of diagnostic studies in patients with massive malignant pleural effusions (56.9% for
cytological studies and 36.9% for biopsies). On the other hand, there was no
difference in the diagnostic yield of microbiological and histological studies in the
group of tuberculous pleural effusions. In our study population, patients with non-
massive malignant pleural effusions had a significantly better survival than those
with massive malignant pleural effusions, with a median survival of 8 months (95%
confidence interval, 7–9) compared with 5 months (95% confidence interval, 4–6)
(P ¼ 0:0009). We conclude that malignancy is the most common cause of a massive
exudative effusion. Massive malignant pleural effusions are associated with worse
survival, independent of age and histologic subgroup, than are non-massive
malignant pleural effusions.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserv
397228.
com (D. Jime´nez).Introduction
It is generally thought that malignancy is the
most common cause of a pleural effusion occupy-
ing the entire hemithorax, especially in oldered.
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Table 1 Etiologies of pleural effusions.
Massive (121) Non-massive (963)
Etiology N % N % P
Malignant 65 53.72 369y 38.31 0.003
Idiopathic 17 14.05 139 14.43 0.98
Parapneumonic 13 10.74 185 19.21 0.03
Cirrhosis 12 9.92 25 2.60 0.0000
Tuberculosis 9 7.44 89 9.24 0.63
Trauma 2 1.65 29 3.01 0.58
CHH 1 0.82 65 6.75 0.02
Transplantation 1 0.82 6 0.62 0.73
Hemothorax 1 0.82 0 0 0.23
PE 0 0 9 0.93 0.59
Serositis 0 0 9 0.93 0.59
Renal disease 0 0 9 0.93 0.59
Chylothorax 0 0 5 0.51 0.95
Others 0 0 24 2.49 0.16
D. Jime´nez et al.1184patients.1 However, the etiology and prognostic
significance of massive pleural effusions remains
largely unknown. Only two case series, both
with a small number of patients, have retrospec-
tively assessed the etiology of massive pleural
effusion.2,3
Therefore, to determine the etiology and prog-
nostic significance of massive pleural effusions, and
to assess the yield of the different techniques
employed in diagnosing pleural pathology, we
prospectively studied the causes and clinical out-
comes of a large series of patients with pleural
effusions at our institution. We hypothesized that
malignancy would be the most common etiology for
massive effusion. We also hypothesized that
massive pleural effusion would be associated with
a poorer prognosis in patients with malignant
pleural effusions.CHH: Congestive heart failure.PE: Pulmonary embolism.
Bronchogenic 39, breast 15, mesothelioma 5, colon 2,
ovarian 1, unknown 3.
yBronchogenic 188, breast 113, colon 13, mesothelioma
12, lymphoma 10, ovarian 9, stomach 5, unknown 15,
others 4.Material and methods
All patients diagnosed with pleural effusion in the
Respiratory Department between March 1991 and
December 2000 were candidates for the study.
Ramo´n y Cajal Hospital is a referred tertiary
medical center in Spain. We prospectively included
all patients who underwent diagnostic thoracent-
esis and signed an informed consent which had
been approved by the institutional review board.
Massive pleural effusion was defined as one that
appeared to occupy the entire hemithorax on a
standard posterior–anterior chest roentgenogram.
The routine study of the pleural fluid included:
pH, biochemical testing of pleura/serum (proteins,
LDH, glucose, cholesterol, triglycerides, albumin
and ADA), hemogram, cytology and microbiological
testing (Gram, Ziehl, aerobic and anaerobic cul-
tures and a mycobacterial culture). Closed pleural
biopsy was performed in the following situations:
suspected malignant pleural effusions, suspected
granulomatous diseases (tuberculosis, connective
disorders and others) and unexplained exudate. At
our facility, closed pleural biopsy is performed at
the same time as the first diagnostic thoracentesis
when there is clinical suspicion of malignancy or
tuberculosis, given its low rate of complications
and the speed with which a diagnosis can be
obtained.
The diagnoses of the patients are listed in
Table 1. All patients underwent a thorough and
uniform diagnostic work-up by two independent
investigators. The definitions for the diagnosis of
the effusions have been previously published.4 We
define an idiopathic pleural effusion as one thatremains undiagnosed despite initial work-up that
includes repeated thoracenteses and pleural
biopsy. All patients with an idiopathic pleural
effusion were followed at least 6 months to exclude
malignancy.Statistical analysis
Statistical analysis was performed using computer
software (SPSS for Windows, version 10.0; SPSS
Inc., Chicago, IL). Results were expressed as mean
7SD unless otherwise stated.
The statistical analyses applied were: the w2 test
with Fisher’s or Yates correction, to analyze the
dependence between qualitative variables, the
non-parametric Mann–Withney U test, for contin-
uous variables with non-normal distribution and
Student’s t-test for those with normal distribution.
Distributions were considered normal or non-nor-
mal as defined by the Saphiro–Wilks test. Survival
curves were calculated by the Kaplan–Meier meth-
od and compared with the log rank test. A Cox
proportional hazards model, using age and histolo-
gical diagnoses as covariates, was used to deter-
mine the independent association between massive
pleural effusions and survival. Significance was
defined as Po0:05 by two-sided test.
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Table 3 Diagnostic yield in malignant pleural
effusions.
Diagnostic yield N (%)
Massive
(65)
Non-massive
(369)
P
Cytology 37 (56.9) 147 (39.8) 0.02
Biopsy 24 (36.9) 101 (27.4) 0.16
Cytology+biopsy 54 (83.1) 234 (63.4) 0.004
Table 4 Diagnostic yield in tuberculous pleural
effusions.
Diagnostic yield N (%)
Massive
(9)
Non-massive
(89)
P
Ziehl effusion 0 (0) 5 (5.6) 0.95
Lowenstein effusion 2 (22.2) 33 (34.8) 0.69
Granulomas 8 (88.9) 69 (68.5) 0.38
Ziehl biopsy 3 (33.3) 18 (16.8) 0.45
Lowenstein biopsy 6 (66.7) 43 (41.6) 0.28
Total 9 (100) 83 (93.2) 0.94
Etiology and prognostic significance of massive pleural effusions 1185Results
Between March 1991 and December 2000, 1084
consecutive patients underwent thoracentesis for
diagnosing a pleural effusion. The mean age was
63:3 17:1 years in those patients with massive
effusions and 63:4 17:4 years in those with non-
massive ones. Massive pleural effusions were
identified in 121 of 1084 patients (11.2%). The
most common cause of massive effusion was
malignancy followed by idiopathic, parapneumonic
and cirrhosis. Massive pleural effusions were
significantly more likely to be malignant or second-
ary to cirrhosis (Table 1) than were non-massive
effusions. On the other hand, massive pleural
effusions were significantly less likely to be second-
ary to infection or congestive heart failure. There
was no significant difference in proportions of
massive and non-massive effusions associated with
tuberculosis, trauma, transplantation, hemothorax
or idiopathic effusions. In addition, none of the
effusions attributed to serositis, pulmonary embo-
lism, renal disease or chylothorax were massive.
There was a significant difference between the
groups of patients with massive and non-massive
effusions regarding RBC count (Table 2).
Because exudative pleural effusions were attrib-
uted to concomitant lung cancer in some cases
without cytologic confirmation, we investigated
whether massive pleural effusions were more likely
to be malignant, as determined by strict cytologic
diagnosis. Malignant cytologic findings were re-
ported in 54 of 121 patients (44.63%) with massive
effusions, compared with 234 of 963 patients with
non-massive effusions (24.30%) (P ¼ 0:0000).
The results of pleural biopsy and cytologic
studies in malignant pleural effusions are listed in
Table 3. In patients with malignant disease there
was a significant increase in the yield of cytological
studies in cases of massive pleural effusions. On the
other hand, there was no difference in the
diagnostic yield of microbiological and histologicalTable 2 Comparison of pleural fluid data between mass
Massive (121)
Characteristics Mean Confidence interval
pH 7.28 7.23–7.33
Glucose (mg/dL) 107 97–122
Protein (mg/dL) 3.9 3.6–4.2
LDH (U/L) 943 474–1411
ADA (U/L) 18.4 14.7–22.0
RBC count (109 cells/L) 1.6 0.28–3
Leukocytes (109 cells/L) 2.2 1.1–3.4studies in the group of tuberculous pleural effusions
(Table 4).
The actual prognosis of patients with massive and
non-massive malignant pleural effusions has not
been determined prospectively. In our study popu-
lation, patients with non-massive malignant pleural
effusions had a significantly better survival than
those with massive malignant pleural effusions,
with a median survival of 8 months (95% confidence
interval, 7–9) compared with 5 months (95%
confidence interval, 4–6) (P ¼ 0:0009) (Fig. 1).
Similarly, the association between pleural fluid
volume and survival remained significant when
age and type of malignancy were entered into a
Cox proportional hazards model. Thus, massiveive and non-massibe pleural effusions.
Non-massive (963)
95% Mean Confidence interval 95% P
7.31 7.28–7.34 0.43
112 108–116 0.58
4.1 4.0–4.2 0.16
1164 824–1504 0.72
20.1 18.1–22.0 0.51
1.1 0.7–3 o0.0001
2.8 2.5–3.2 0.18
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Figure 2 Survival for massive and non-massive idiopathic
pleural effusions. Cumulative survival was calculated by
the Kaplan–Meier method for massive and non-massive
effusions.
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Median survival for nonmassive effusions: 8 months 
Median survival for massive efussions: 5 months 
p = 0.0009 
Figure 1 Survival for massive and non-massive malignant
pleural effusions. Cumulative survival was calculated by
the Kaplan–Meier method for massive and non-massive
effusions.
D. Jime´nez et al.1186pleural effusions appeared to be associated with a
worse prognosis in patients with a diagnosis of
malignancy.
On the other hand, there was no difference in
survival between massive and non-massive pleural
effusions in the group of idiopathic effusions, with
a median survival of 45 months (95% confidence
interval, 30–60) compared with 45 months (95%
confidence interval, 43–47) (P ¼ 0:62) (Fig. 2).Discussion
This large prospective study of consecutive
thoracenteses performed over a 10-year periodconfirms the generally held impression that malig-
nancy is the most common cause of massive pleural
effusion.5 Although autopsies have indicated that
impaired lymphatic drainage from the pleural
space is the predominant mechanism for the
accumulation of fluid associated with malig-
nancy,6,7 the actual mechanism is not known.8
However, as there was no difference in the
mediastinal involvement between massive and
non-massive malignant effusions (data not shown),
and cytological yield was higher in massive effu-
sions, we postulate that the volume of the effusion
depends on the extent of pleural involvement by
metastasis.
The results in the present study in which 54% of
massive effusions were due to malignancy demon-
strate a lower prevalence of malignancy for
massive effusions than do the series of Maher and
Berger (67% of 46 patients)2 or the series of Pedro
et al. (71.4% of 84 patients).3 However, neither of
these papers reported the percent of idiopathic
effusions. Following different diagnostic proce-
dures, approximately 20% of patients still have
undiagnosed conditions.9,10 In our series, 14.4% of
patients remained undiagnosed and this could
explain our lower prevalence of malignancy causing
massive effusions.
Cirrhosis of the liver was the most common cause
of a massive transudative pleural effusion. The most
likely cause is a transfer of a large volume of fluid
from the abdomen to the pleural space via defects in
the diaphragm.11 In these cases, repair of these
defects using videothoracoscopy may be consid-
ered.12 In our series, 11 of these effusions were
unilateral on the right, so that finding a large
unilateral right sided transudate is very suggestive
of this diagnosis. On the other hand, a diagnostic
thoracentesis should always be performed in a patient
with a suspected diagnosis of congestive heart failure
in the presence of massive pleural effusion.
Malignant pleural effusions can be diagnosed only
by demonstrating malignant cells in pleural fluid or
pleural tissue. Cytology is a more sensitive test for
the diagnosis than percutaneous pleural biopsy,
because pleural metastases tend to be focal and
the latter is a blind sampling procedure.13–15 It has
been recommended that several hundreds of
millilitres of pleural fluid should be removed at
the initial diagnostic thoracentesis if malignancy is
suspected.16 This manoeuvre will not improve the
yield on the initial study but, if it is negative,
a repeat procedure several days later may
provide fluid with fewer degenerated cells and
more freshly exfoliated malignant cells. Our
results demonstrate that the yield from cytological
diagnosis is significantly higher in malignant mas-
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involvement could explain the presence of massive
pleural effusion and the higher yield from exfolia-
tive cytology. This hypothesis also explains the
higher diagnostic yield of biopsy procedures.
Finally, to our knowledge, our study provides the
first documentation of a significant association
between massive pleural effusions and worse
survival in malignant effusions. This association
remained significant after adjustment for age and
histological diagnosis. Previous studies have noted
a correlation between the survival of patients with
malignant pleural effusions and the extent of tumor
spread on pleural membranes as defined by pleural
fluid pH.7,17 Again, massive pleural effusion can be
a marker of extensive pleural involvement and a
predictor of survival.
In conclusion, malignancy is the most common
cause of massive exudative effusions while cirrhosis
of liver is the most common cause of massive
transudative effusions. With malignant effusions,
the diagnostic yield of cytologic studies signifi-
cantly increases if the effusions is massive. There is
no difference in the diagnostic yield of pleural
biopsy or microbiological studies between massive
or non-massive tuberculous pleural effusions. Mas-
sive effusions are associated with a worse prognosis
in patients with malignant effusions but not in
patients with benign effusions.References
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